BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jang SY, Tak WY, Park SY, Kweon YO, Lee YR, Kim G, Hur K, Han MH, Lee WK. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases. Ann Lab Med 2021;41:302-9. [PMID: 33303715 DOI: 10.3343/alm.2021.41.3.302] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Tsai T, Hsu P, Wu C, Huang S, Chan W, Lin S, Chen J, Lu T, Leu H. Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores. Nutrients 2022;14:3163. [DOI: 10.3390/nu14153163] [Reference Citation Analysis]
2 Kwon Y, Kim ES, Choe YH, Kim MJ. Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children. Front Pediatr 2022;10:846273. [PMID: 35444966 DOI: 10.3389/fped.2022.846273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nam M, Hur M, Park M, Kim H. Novel Usefulness of Krebs von den Lungen 6 (KL-6) with Hemoglobin and Lactate Dehydrogenase for Assessing Bone Marrow Fibrosis. Diagnostics 2022;12:628. [DOI: 10.3390/diagnostics12030628] [Reference Citation Analysis]
4 Hur M, Park M, Moon HW, Choe WH, Lee CH. Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer. Ann Lab Med 2022;42:249-57. [PMID: 34635616 DOI: 10.3343/alm.2022.42.2.249] [Reference Citation Analysis]
5 Jang TY, Huang CF, Yeh ML, Huang CI, Dai CY, Tsai PC, Hsu PY, Wei YJ, Hou NJ, Liang PC, Lin YH, Wang CW, Hsieh MY, Lin ZY, Huang JF, Yu ML, Chuang WL. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients. Kaohsiung J Med Sci 2021. [PMID: 34786828 DOI: 10.1002/kjm2.12474] [Reference Citation Analysis]
6 Krasner YA, Osipenko MF, Litvinova NV, Bikbulatova EA, Holin SI, Klimotov VV. Non-alcoholic fatty liver disease - a look at diagnostic prospects. jour 2021. [DOI: 10.31146/1682-8658-ecg-191-7-62-67] [Reference Citation Analysis]
7 Facciorusso A, Ramai D, Conti Bellocchi MC, Bernardoni L, Manfrin E, Muscatiello N, Crinò SF. Diagnostic Yield of Endoscopic Ultrasound-Guided Liver Biopsy in Comparison to Percutaneous Liver Biopsy: A Two-Center Experience. Cancers (Basel) 2021;13:3062. [PMID: 34205389 DOI: 10.3390/cancers13123062] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
8 Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med (Lausanne) 2021;8:615978. [PMID: 33937277 DOI: 10.3389/fmed.2021.615978] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 30.0] [Reference Citation Analysis]